RxSight, Inc. $(RXST)$ is currently at $33.18, down $5.01 or 13.12%
--Would be lowest close since Dec. 5, 2023, when it closed at $32.99
--On pace for largest percent decrease since June 21, 2022, when it fell 16.36%
--Currently down three of the past four days
--Down 29.22% month-to-date
--Down 17.71% year-to-date; on pace for worst year on record (Based on available data back to July 30, 2021)
--Down 48.39% from its all-time closing high of $64.29 on May 15, 2024
--Down 16.30% from 52 weeks ago (Dec. 22, 2023), when it closed at $39.64
--Down 48.39% from its 52-week closing high of $64.29 on May 15, 2024
--Would be a new 52-week closing low
--Traded as low as $33.03; lowest intraday level since Dec. 6, 2023, when it hit $32.88
--Down 13.51% at today's intraday low; largest intraday percent decrease since Nov. 8, 2024, when it fell as much as 16.32%
All data as of 3:34:11 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
December 20, 2024 15:35 ET (20:35 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.